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Dear Editor,
Hereditary spherocytosis (HS) is the most frequent congen-
ital haemolytic anaemia in Caucasians. β-spectrin defects are
typically inherited in an autosomal dominant manner with the
clinical presentation of HS [5, 9].We report on a newmutation
in the SPTB gene (466insG) leading to a frameshift and a
premature stop codon 29 codons downstream in the region
encoding the C-terminal part of the dimerization domain.
Most probably, instability of mutant mRNA results in spectrin
deficiency and clinically moderate to serious HS.
The N-terminal region of the β-spectrin subunit con-
sists of actin-binding domain and located downstream the
dimerization domain consisting of the first two spectrin
repeats. During our studies on HS cases in the population
of Western Poland, we found a new mutation in a family
with autosomal dominant HS [2–4]. Patients with moder-
ate symptoms of the disease were recruited: mother (C10,
splenectomized) and children (C14, C9), age ranged from
27 to 67 years. Diagnostic criteria for HS were based on
typical features: spherocytes on peripheral blood smears,
increased osmotic fragility, splenomegaly, increased bili-
rubin, reticulocytosis, anaemia and symptoms of gallstone
disease (Supplemental Table I). The Ethics Committee of
the Medical University of Wroclaw approved the study
protocol. Informed consent was obtained from all patients
and healthy individuals serving as a control before enter-
ing the protocol.
Molecular genetic analyses of the studied patients and
the unaffected family members were performed. The nu-
cleotide sequence of the ANK1, SPTB and SLC4A1 genes
were amplified by PCR from genomic DNA. During DNA
analysis of these genes, several common polymorphisms
were encountered (Supplemental Table II). DNA sequenc-
ing revealed that all of the studied patients were heterozy-
gous for novel mutation 466insG in the exon 11 of the
SPTB gene (Fig. 1a, b).
RBC membrane protein gel electrophoresis demonstrat-
ed deficiency of some membrane proteins: β-spectrin and
ankyrin-1, thereby supporting the diagnosis of HS (data
not shown). Immunoblotting of erythrocyte membrane
ghosts from C14 and C10 patients with this mutation with
antibody recognising an actin binding domain of β-
spectrin [10] could not detect a truncated protein (data
not shown), suggesting that this mutant transcript might
be unstable.
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Next, we assessed the presence of the mutant mRNA tran-
scripts. Loss of mutant allele in the cDNA in relation to the
genomic DNAwas observed (Fig. 1c), indicating that the mu-
tant mRNA transcript was not present to detectable levels.
Frameshift mutations of the SPTB gene associated with HS
have been previously reported and in some cases the mutant
mRNA could not be detected or was detected in decreased
levels [1, 6–8]. Also, the truncated protein could be observed
in the erythrocyte or reticulocyte membrane [7]. As in the
studied family the presence of mutated mRNA or truncated
protein was not observed in the reticulocytes/erythrocytes, we
conclude that in the studied family members probably
monoallelic expression of the SPTB gene takes place which
results in spectrin deficiency. This in consequence is a reason
for a decreased surface density of the membrane skeleton and
disturbed support of themembrane lipid bilayer and hereditary
spherocytosis.
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